“`html
Generative and agentic artificial intelligence (Gen AI and agentic AI) are revolutionizing medical devices globally, enhancing clinical workflows and patient care. Notably, Gen AI is utilized for creating synthetic medical images (MRI, CT, X-rays) to improve diagnostic tools and augment datasets. In 2023, the FDA approved over 700 AI-enabled devices, a significant increase from the previous two years, boosting innovation and faster approval processes.
NVIDIA co-founded the Medical Open Network for AI (MONAI) to foster collaboration among AI researchers in healthcare imaging. Major companies integrating AI include Boston Scientific, which has projected a 16.4% sales growth for 2025 driven by AI advancements; Johnson & Johnson, with its AI-driven surgical platforms expecting a 2.8% sales growth; and GE HealthCare, which leads the FDA with 80 AI-enabled devices and a projected 3.2% sales growth for 2025.
Key features driving AI adoption in medical devices include the demand for personalized medicine and a favorable regulatory environment. Technologies like real-time clinical documentation tools and AI-guided robotic systems are becoming integral in medical procedures, thus enhancing operational efficiency and patient outcomes.
“`